Approaching clinical proteomics: Current state and future fields of application in fluid proteomics

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 6, 2009, Pages 724-744

  Apweiler, Rolf ^a   Aslanidis, Charalampos ^b   Deufel, Thomas ^c   Gerstner, Andreas ^d   Hansen, Jens ^b   Hochstrasser, Dennis ^e   Kellner, Roland ^f   Kubicek, Markus ^g   Lottspeich, Friedrich ^h   Maser, Edmund ⁱ   Mewes, Hans Werner ^j   Meyer, Helmut E ^k   Müllner, Stefan ^l   Mutter, Wolfgang ^m   Neumaier, Michael ⁿ   Nollau, Peter ^o   Nothwang, Hans G ^p   Ponten, Fredrik ^q   Radbruch, Andreas ^r   Reinert, Knut ^s   Rothe, Gregor ^t   Stockinger, Hannes ^g   Tarnok, Attila ^u   Taussig, Mike J ^v   Thiel, Andreas ^r   Thiery, Joachim ^u   Ueffing, Marius ^j   Valet, Günther ^h   Vandekerckhove, Joel ^w   Verhuven, Wiltrud ^x   Wagener, Christoph ^o   Wagner, Oswald ^g   Schmitz, Gerd ^b   more..

^a EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d UNIVERSITY OF BONN   (Germany)

^e UNIVERSITY OF GENEVA   (Switzerland)

^f MERCK KGAA   (Germany)

^g UNIVERSITY OF VIENNA   (Austria)

^h MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

ⁱ UNIVERSITY OF KIEL   (Germany)

^j INSTITUTE OF EPIDEMIOLOGY   (Germany)

^k RUHR UNIVERSITY BOCHUM   (Germany)

^l PROTAGEN AG   (Germany)

^m PROFOS AG   (Germany)

ⁿ UNIVERSITY OF HEIDELBERG   (Germany)

^o UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^p Rheinland Pfälzische Technische Universität Kaiserslautern Landau   (Germany)

^q UPPSALA UNIVERSITY   (Sweden)

^r German Rheumatism Research Center   (Germany)

^s HUMBOLDT UNIVERSITY   (Germany)

^t Laboratory Center Bremen   (Germany)

^u UNIVERSITY OF LEIPZIG   (Germany)

^v BABRAHAM INSTITUTE   (United Kingdom)

^w GHENT UNIVERSITY   (Belgium)

^x Waters   (Germany)

more..

Author keywords

Cerebrospinal fluid (CSF); Clinical proteomics; Fluid proteomics; Mass spectrometry (MS); Matrix assisted laser desorption ionization (MALDI); Preanalytical effects; Standard operating procedures (SOP); Surface enhanced laser desorption ionization (SELDI)

Indexed keywords

PROTEOME;

ANALYTICAL ERROR; ANALYTICAL PARAMETERS; BIOINFORMATICS; BLOOD ANALYSIS; BODY FLUID; CAPILLARY ELECTROPHORESIS; CAPILLARY ZONE ELECTROPHORESIS; CEREBROSPINAL FLUID ANALYSIS; CLINICAL CHEMISTRY; CLINICAL MEDICINE; DISEASE MARKER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; LABORATORY DIAGNOSIS; LABORATORY TEST; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROARRAY ANALYSIS; PEPTIDE ANALYSIS; PEPTIDOMICS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN MICROARRAY; PROTEOMICS; QUALITY CONTROL; REVIEW; STANDARDIZATION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; URINALYSIS;

BIOLOGICAL MARKERS; BODY FLUIDS; CLINICAL MEDICINE; PROTEINS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 67650602912     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.167     Document Type: Review

References (162)

1. Liotta LA, Ferrari M, Petricoin E. Clinical proteomics: written in blood. Nature 2003;425:905.
2. Liotta LA, Petricoin EF. Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold. J Clin Invest 2006;116:26-30.
3. Paik YK, Kim H, Lee EY, Kwon MS, Cho SY. Overview and introduction to clinical proteomics. Methods Mol Biol 2008;428:1-31.
4. Luque-Garcia JL, Neubert TA. Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometry. J Chromatogr A 2007;1153:259-76.
5. Lippi G, Salvagno GL, Montagnana M, Guidi GC. Reliability of the thrombin-generation assay in frozen-thawed platelet-rich plasma. Clin Chem 2006;52:1827-8.
6. Conrads TP, Hood BL, Veenstra TD. Sampling and analytical strategies for biomarker discovery using mass spectrometry. Biotechniques 2006;40:799-805.
7. Ferguson RE, Hochstrasser DF. Impact of preanalytical variables on the analysis of biological fluids in proteomic studies. Proteomics-Clin Appl 2007;1:739-46.
8. Lippi G, Blanckaert N, Bonini P, Green S, Kitchen S, Palicka V, et al. Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin Chem Lab Med 2008;46:764-72.
9. Lippi G, Salvagno GL, Montagnana M, Brocco G, Guidi GC. Influence of hemolysis on routine clinical chemistry testing. Clin Chem Lab Med 2006;44:311-6.
10. Guder WG. Haemolysis as an influence and interference factor in clinical chemistry. J Clin Chem Clin Biochem 1986;24:125-6.
11. Sonntag O. Haemolysis as an interference factor in clinical chemistry. J Clin Chem Clin Biochem 1986;24:127- 39.
12. Grafmeyer D, Bondon M, Manchon M, Levillain P. The influence of bilirubin, haemolysis and turbidity on 20 analytical tests performed on automatic analysers. Results of an interlaboratory study. Eur J Clin Chem Clin Biochem 1995;33:31-52.
13. Jay DW, Provasek D. Characterization and mathematical correction of hemolysis interference in selected Hitachi 717 assays. Clin Chem 1993;39:1804-10.
14. Kroll MH, Elin RJ. Interference with clinical laboratory analyses. Clin Chem 1994;40:1996-2005.
15. Steen G, Vermeer HJ, Naus AJ, Goevaerts B, Agricola PT, Schoenmakers CH. Multicenter evaluation of the interference of hemoglobin, bilirubin and lipids on Synchron LX-20 assays. Clin Chem Lab Med 2006;44:413-9.
16. Hsieh SY, Chen RK, Pan YH, Lee HL. Systematical evaluation of the effects of sample collection procedures on low-molecular-weight serum/plasma proteome profiling. Proteomics 2006;6:3189-98.
17. Munro NP, Cairns DA, Clarke P, Rogers M, Stanley AJ, Barrett JH, et al. Urinary biomarker profiling in transitional cell carcinoma. Int J Cancer 2006;119:2642-50.
18. Statland BE, Winkel P, Bokelund H. Factors contributing to intra-individual variation of serum constituents. 1. Within-day variation of serum constituents in healthy subjects. Clin Chem 1973;19:1374-9.
19. Schaub S, Wilkins J, Weiler T, Sangster K, Rush D, Nic-kerson P. Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int 2004;65:323-32.
20. Petri AL, Hogdall CK, Christensen IJ, Simonsen AH, T'Jampens D, Hellmann M-L, et al. Sample handling for mass spectrometric proteomic investigations of human urine. Proteomics-Clin Appl 2009;2:1184-93.
21. Lippi G, Salvagno GL, Brocco G, Guidi GC. Preanalytical variability in laboratory testing: influence of the blood drawing technique. Clin Chem Lab Med 2005;43:319- 25.
22. Lippi G, Salvagno GL, Montagnana M, Poli G, Guidi GC. Influence of the needle bore size on platelet count and routine coagulation testing. Blood Coagul Fibrin 2006; 17:557-61.
23. Statland BE, Winkel P, Bokelund H. Factors contributing to intra-individual variation of serum constituents. 2. Effects of exercise and diet on variation of serum constituents in healthy subjects. Clin Chem 1973;19:1380- 3.
24. Banks RE, Stanley AJ, Cairns DA, Barrett JH, Clarke P, Thompson D, Selby PJ. Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry. Clin Chem 2005;51:1637-49.
25. Baumann S, Ceglarek U, Fiedler GM, Lembcke J, Leichtle A, Thiery J. Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem 2005;51:973-80.
26. Rai AJ, Gelfand CA, Haywood BC, Warunek DJ, Yi J, Schuchard MD, et al. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 2005;5:3262-77.
27. Tammen H, Schulte I, Hess R, Menzel C, Kellmann M, Mohring T, et al. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display. Proteomics 2005;5:3414-22.
28. Sahu A, Lambris JD. Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol Rev 2001;180:35-48.
29. Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, Olshen AB, et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest 2006;116:271-84.
30. Albrethsen J, Bogebo R, Olsen J, Raskov H, Gammeltoft S. Preanalytical and analytical variation of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry of human serum. Clin Chem Lab Med 2006;44:1243-52.
31. Lewczuk P, Beck G, Esselmann H, Bruckmoser R, Zimmermann R, Fiszer M, et al. Effect of sample collection tubes on cerebrospinal fluid concentrations of tau proteins and amyloid beta peptides. Clin Chem 2006;52: 332-4.
32. Drake SK, Bowen RA, Remaley AT, Hortin GL. Potential interferences from blood collection tubes in mass spectrometric analyses of serum polypeptides. Clin Chem 2004;50:2398-401.
33. Mei H, Hsieh Y, Nardo C, Xu X, Wang S, Ng K, et al. Investigation of matrix effects in bioanalytical high-performance liquid chromatography/tandem mass spectro-metric assays: application to drug discovery. Rapid Commun Mass Spectrom 2003;17:97-103.
34. West-Nielsen M, Hogdall EV, Marchiori E, Hogdall CK, Schou C, Heegaard NH. Sample handling for mass spectrometric proteomic investigations of human sera. Anal Chem 2005;77:5114-23.
35. Engwegen JY, Alberts M, Knol JC, Jimenez CR, Depla AC, Tuynman H, et al. Influence of variations in sample handling on SELDI-TOF MS serum protein profiles for colorectal cancer. Proteomics-Clin Appl 2008;2:936-45.
36. Carrette O, Burkhard PR, Hughes S, Hochstrasser DF, Sanchez JC. Truncated cystatin C in cerebrospiral fluid: Technical wcorrectedx artefact or biological process? Proteomics 2005;5:3060-5.
37. Irani DN, Anderson C, Gundry R, Cotter R, Moore S, Kerr DA, et al. Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis. Ann Neurol 2006;59:237-47.
38. Hansson SF, Simonsen AH, Zetterberg H, Andersen O, Haghighi S, Fagerberg I, et al. Cystatin C in cerebrospinal fluid and multiple sclerosis. Ann Neurol 2007;62: 193-6.
39. Bons JA, de BD, van Dieijen-Visser MP, Wodzig WK. Standardization of calibration and quality control using surface enhanced laser desorption ionization-time of flight-mass spectrometry. Clin Chim Acta 2006;366: 249-56.
40. Petricoin EF III, Ornstein DK, Paweletz CP, Ardekani A, Hackett PS, Hitt BA, et al. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 2002; 94:1576-8.
41. Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 2002;62:3609-14.
42. Qu Y, Adam BL, Yasui Y, Ward MD, Cazares LH, Schell-hammer PF, et al. Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clin Chem 2002;48:1835-43.
43. Mischak H, Apweiler R, Banks RE, Conaway M, Coon J, Dominiczak A, et al. Clinical proteomics: a need to define the field and to begin to set adequate standards. Proteo-mics-Clin Appl 2006;1:148-56.
44. Marshall J, Kupchak P, Zhu W, Yantha J, Vrees T, Furesz S, et al. Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. J Proteome Res 2003;2:361-72.
45. Shaw J, Rowlinson R, Nickson J, Stone T, Sweet A, Williams K, et al. Evaluation of saturation labelling two-dimensional difference gel electrophoresis fluorescent dyes. Proteomics 2003;3:1181-95.
46. Nedelkov D. Population proteomics: addressing protein diversity in humans. Expert Rev Proteomics 2005;2: 315-24.
47. Semmes OJ, Feng Z, Adam BL, Banez LL, Bigbee WL, Campos D, et al. Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. Clin Chem 2005;51:102-12.
48. Klose J, Kobalz U. Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome. Electrophoresis 1995; 16:1034-59.
49. Cristea IM, Gaskell SJ, Whetton AD. Proteomics techniques and their application to hematology. Blood 2004; 103:3624-34.
50. Rees-Unwin KS, Morgan GJ, Davies FE. Proteomics and the haematologist. Clin Lab Haematol 2004;26:77-86.
51. Hoving S, Voshol H, van OJ. Towards high performance two-dimensional gel electrophoresis using ultrazoom gels. Electrophoresis 2000;21:2617-21.
52. Berggren KN, Schulenberg B, Lopez MF, Steinberg TH, Bogdanova A, Smejkal G, et al. An improved formulation of SYPRO Ruby protein gel stain: comparison with the original formulation and with a ruthenium II tris (batho-phenanthroline disulfonate) formulation. Proteomics 2002;2:486-98.
53. Lanne B, Panfilov O. Protein staining influences the quality of mass spectra obtained by peptide mass fingerprinting after separation on 2-d gels. A comparison of staining with coomassie brilliant blue and sypro ruby. J Proteome Res 2005;4:175-9.
54. Nishihara JC, Champion KM. Quantitative evaluation of proteins in one- and two-dimensional polyacrylamide gels using a fluorescent stain. Electrophoresis 2002;23: 2203-15.
55. Page MJ, Griffiths TA, Bleackley MR, MacGillivray RT. Proteomics: applications relevant to transfusion medicine. Transfus Med Rev 2006;20:63-74.
56. Thiele T, Steil L, Volker U, Greinacher A. Proteomics of blood-based therapeutics: a promising tool for quality assurance in transfusion medicine. BioDrugs 2007;21: 179-93.
57. Lilley KS, Razzaq A, Dupree P. Two-dimensional gel electrophoresis: recent advances in sample preparation, detection and quantitation. Curr Opin Chem Biol 2002; 6:46-50.
58. O'Farrell PZ, Goodman HM, O'Farrell PH. High resolution two-dimensional electrophoresis of basic as well as acidic proteins. Cell 1977;12:1133-41.
59. Wittmann-Liebold B, Graack HR, Pohl T. Two-dimensional gel electrophoresis as tool for proteomics studies in combination with protein identification by mass spectrometry. Proteomics 2006;6:4688-703.
60. Unlu M, Morgan ME, Minden JS. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 1997;18:2071-7.
61. Alban A, David SO, Bjorkesten L, Andersson C, Sloge E, Lewis S, Currie I. A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 2003;3:36-44.
62. Roe MR, Griffin TJ. Gel-free mass spectrometry-based high throughput proteomics: tools for studying biological response of proteins and proteomes. Proteomics 2006;6:4678-87.
63. Stasyk T, Huber LA. Zooming in: fractionation strategies in proteomics. Proteomics 2004;4:3704-16.
64. Martosella J, Zolotarjova N, Liu H, Nicol G, Boyes BE. Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins. J Proteome Res 2005;4:1522-37.
65. Link AJ, Eng J, Schieltz DM, Carmack E, Mize GJ, Morris DR, et al. Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol 1999;17:676-82.
66. Washburn MP, Wolters D, Yates JR III. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 2001;19:242- 7.
67. Mayya V, Rezaul K, Cong YS, Han D. Systematic comparison of a two-dimensional ion trap and a three-dimensional ion trap mass spectrometer in proteomics. Mol Cell Proteomics 2005;4:214-23.
68. Tabb DL, MacCoss MJ, Wu CC, Anderson SD, Yates JR III. Similarity among tandem mass spectra from proteo-mic experiments: detection, significance, and utility. Anal Chem 2003;75:2470-7.
69. Johannesson N, Wetterhall M, Markides KE, Bergquist J. Monomer surface modifications for rapid peptide analysis by capillary electrophoresis and capillary electrochromatography coupled to electrospray ionizationmass spectrometry. Electrophoresis 2004;25:809-16.
70. Kolch W, Neususs C, Pelzing M, Mischak H. Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery. Mass Spectrom Rev 2005;24:959-77.
71. Hernandez-Borges J, Neususs C, Cifuentes A, Pelzing M. On-line capillary electrophoresis-mass spectrometry for the analysis of biomolecules. Electrophoresis 2004;25: 2257-81.
72. Neususs C, Pelzing M, Macht M. A robust approach for the analysis of peptides in the low femtomole range by capillary electrophoresis-tandem mass spectrometry. Electrophoresis 2002;23:3149-59.
73. Theodorescu D, Fliser D, Wittke S, Mischak H, Krebs R, Walden M, et al. Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine. Electrophoresis 2005;26:2797-808.
74. Huang YF, Huang CC, Hu CC, Chang HT. Capillary elec-trophoresis-based separation techniques for the analysis of proteins. Electrophoresis 2006;27:3503-22.
75. Burkitt WI, Derrick PJ, Lafitte D, Bronstein I. Proteinligand and protein-protein interactions studied by electrospray ionization and mass spectrometry. Biochem Soc Trans 2003;31:985-9.
76. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science 1989;246:64-71.
77. Karas M, Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal Chem 1988;60:2299-301.
78. Salzano AM, Crescenzi M. Mass spectrometry for protein identification and the study of posttranslational modifications. Ann Ist Super Sanita 2005;41:443-50.
79. Craig R, Beavis RC. TANDEM: matching proteins with tandem mass spectra. Bioinformatics 2004;20:1466-7.
80. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999;20:3551-67.
81. Yates JR III, Eng JK, McCormack AL, Schieltz D. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal Chem 1995;67:1426-36.
82. Colinge J, Masselot A, Giron M, Dessingy T, Magnin J. OLAV: towards high-throughput tandem mass spectrometry data identification. Proteomics 2003;3:1454- 63.
83. Colinge J, Magnin J, Dessingy T, Giron M, Masselot A. Improved peptide charge state assignment. Proteomics 2003;3:1434-40.
84. Hortin GL. The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome. Clin Chem 2006;52:1223-37.
85. Berhane BT, Zong C, Liem DA, Huang A, Le S, Edmond-son RD, et al. Cardiovascular-related proteins identified in human plasma by the HUPO Plasma Proteome Project pilot phase. Proteomics 2005;5:3520-30.
86. Donahue MP, Rose K, Hochstrasser D, Vonderscher J, Grass P, Chibout SD, et al. Discovery of proteins related to coronary artery disease using industrial-scale proteo-mics analysis of pooled plasma. Am Heart J 2006; 152:478-85.
87. Simpkins F, Czechowicz JA, Liotta L, Kohn EC. SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics. Pharmacogenomics 2005;6:647-53.
88. Poon TC. Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices. Expert Rev Proteomics 2007;4:51-65.
89. Wingren C, Borrebaeck CA. Antibody microarrays: current status and key technological advances. OMICS 2006;10:411-27.
90. van Venrooij WJ, Zendman AJ, Pruijn GJ. Autoantibod-ies to citrullinated antigens in (early) rheumatoid arthritis wreviewx. Autoimmun Rev 2006;6:37-41.
91. Horn S, Lueking A, Murphy D, Staudt A, Gutjahr C, Schulte K, et al. Profiling humoral autoimmune repertoire of dilated cardiomyopathy (DCM) patients and development of a disease-associated protein chip. Proteomics 2006;6:605-13.
92. Stephan C, Reidegeld KA, Hamacher M, van HA, Marcus K, Taylor C, et al. Automated reprocessing pipeline for searching heterogeneous mass spectrometric data ofthe HUPO Brain Proteome Project pilot phase. Proteomics 2006;6:5015-29.
93. Lueking A, Huber O, Wirths C, Schulte K, Stieler KM, Blume-Peytavi U, et al. Profiling of alopecia areata autoantigens based on protein microarray technology. Mol Cell Proteomics 2005;4:1382-90.
94. Robinson WH, DiGennaro C, Hueber W, Haab BB, Kamachi M, Dean EJ, et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med 2002;8:295-301.
95. Gannot G, Tangrea MA, Gillespie JW, Erickson HS, Wallis BS, Leakan RA, et al. Layered peptide arrays: highthroughput antibody screening of clinical samples. J Mol Diagn 2005;7:427-36.
96. Wilson R, Cossins AR, Spiller DG. Encoded microcarriers for high-throughput multiplexed detection.Angew Chem Int Ed Engl 2006;45:6104-17.
97. Vignali DA. Multiplexed particle-based flow cytometric assays. J Immunol Methods 2000;243:243-55.
98. Kellar KL, Iannone MA. Multiplexed microsphere-based flow cytometric assays. Exp Hematol 2002;30:1227-37.
99. Kellar KL, Douglass JP. Multiplexed microsphere-based flow cytometric immunoassays for human cytokines. J Immunol Methods 2003;279:277-85.
100. Edelmann L, Hashmi G, Song Y, Han Y, Kornreich R, Desnick RJ. Cystic fibrosis carrier screening: validation of a novel method using BeadChip technology. Genet Med 2004;6:431-8.
101. Lukacs Z, Dietrich A, Ganschow R, Kohlschutter A, Kruithof R. Simultaneous determination of HIV antibodies, hepatitis C antibodies, and hepatitis B antigens in dried blood spots-a feasibility study using a multi-analyte immunoassay. Clin Chem Lab Med 2005;43:141-5.
102. Bellisario R, Colinas RJ, Pass KA. Simultaneous measurement of antibodies to three HIV-1 antigens in newborn dried blood-spot specimens using a multiplexed microsphere-based immunoassay. Early Hum Dev 2001;64:21-5.
103. Bellisario R, Colinas RJ, Pass KA. Simultaneous measurement of thyroxine and thyrotropin from newborn dried blood-spot specimens using a multiplexed fluorescent microsphere immunoassay. Clin Chem 2000;46: 1422-4.
104. Luo Y. Selectivity assessment of kinase inhibitors: strategies and challenges. Curr Opin Mol Ther 2005;7:251- 5.
105. Whitehead GS, Walker JK, Berman KG, Foster WM, Schwartz DA. Allergen-induced airway disease is mouse strain dependent. Am J Physiol Lung Cell Mol Physiol 2003;285:L32-42.
106. Hurley JD, Engle LJ, Davis JT, Welsh AM, Landers JE. A simple, bead-based approach for multi-SNP molecular haplotyping. Nucleic Acids Res 2004;32:e186.
107. Yan X, Zhong W, Tang A, Schielke EG, Hang W, Nolan JP. Multiplexed flow cytometric immunoassay for influenza virus detection and differentiation. Anal Chem 2005;77:7673-8.
108. McBride MT, Gammon S, Pitesky M, O'Brien TW, Smith T, Aldrich J, et al. Multiplexed liquid arrays for simultaneous detection of simulants of biological warfare agents. Anal Chem 2003;75:1924-30.
109. Fritzler MJ, Fritzler ML. The emergence of multiplexed technologies as diagnostic platforms in systemic autoimmune diseases. Curr Med Chem 2006;13:2503-12.
110. Stoll D, Templin MF, Bachmann J, Joos TO. Protein microarrays: applications and future challenges. Curr Opin Drug Discov Devel 2005;8:239-52.
111. Lund-Johansen F, Davis K, Bishop J, de Waal MR. Flow cytometric analysis of immunoprecipitates: high-throughput analysis of protein phosphorylation and protein-protein interactions 1. Cytometry 2000;39:250- 9.
112. Tomer A, Koziol J, McMillan R. Autoimmune throm-bocytopenia: flow cytometric determination of platelet-associated autoantibodies against platelet-specific receptors 1. J Thromb Haemost 2005;3:74-8.
113. Glocker MO, Ringel B, Gotze L, Lorenz S, Wandschnei-der V, Fehring V, et al. Klinische Proteomforschung. In: Gabrielczyk S, editors. Laborwelt. Berlin: Verlag der BIOCOM AG, 2000:7-12.
114. Sinz A, Bantscheff M, Mikkat S, Ringel B, Drynda S, Kekow J, et al. Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison to reactive arthritis or osteoarthritis. Electrophoresis 2002;23: 3445-56.
115. Theodorescu D, Wittke S, Ross MM, Walden M, Cona-way M, Just I, et al. Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. Lancet Oncol 2006;7:230-40.
116. Fiedler GM, Baumann S, Leichtle A, Oltmann A, Kase J, Thiery J, et al. Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem 2007;53:421-8.
117. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002;1:845-67.
118. Righetti PG, Castagna A, Antonucci F, Piubelli C, Cecconi D, Campostrini N, et al. Proteome analysis in the clinical chemistry laboratory: myth or reality? Clin Chim Acta 2005;357:123-39.
119. Lee HJ, Lee EY, Kwon MS, Paik YK. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics. Curr Opin Chem Biol 2006;10: 42-9.
120. Qian WJ, Jacobs JM, Liu T, Camp DG, Smith RD. Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications. Mol Cell Proteomics 2006;5:1727-44.
121. Omenn GS, States DJ, Adamski M, Blackwell TW, Menon R, Hermjakob H, et al. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 2005;5: 3226-45.
122. Fliser D, Novak J, Thongboonkerd V, Argiles A, Jan-kowski V, Girolami MA, et al. Advances in urinary proteome analysis and biomarker discovery. J Am Soc Nephrol 2007;18:1057-71.
123. Thongboonkerd V, McLeish KR, Arthur JM, Klein JB. Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. Kidney Int 2002;62:1461-9.
124. Oh J, Pyo JH, Jo EH, Hwang SI, Kang SC, Jung JH, et al. Establishment of a near-standard two-dimensional human urine proteomic map. Proteomics 2004;4: 3485-97.
125. Pieper R, Gatlin CL, McGrath AM, Makusky AJ, Mondal M, Seonarain M, et al. Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics 2004;4:1159-74.
126. Sun T, Ye F, Ding H, Chen K, Jiang H, Shen X. Protein tyrosine phosphatase 1B regulates TGF beta 1-induced Smad2 activation through PI3 kinase-dependent pathway. Cytokine 2006;35:88-94.
127. Adachi J, Kumar C, Zhang Y, Olsen JV, Mann M. The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol 2006;7:R80.
128. Neuhoff N, Kaiser T, Wittke S, Krebs R, Pitt A, Burchard A, et al. Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry. Rapid Commun Mass Spectrom 2004;18:149-56.
129. Kaiser T, Hermann A, Kielstein JT, Wittke S, Bartel S, Krebs R, et al. Capillary electrophoresis coupled to mass spectrometry to establish polypeptide patterns in dialysis fluids. J Chromatogr A 2003;1013:157-71.
130. Mischak H, Kaiser T, Walden M, Hillmann M, Wittke S, Herrmann A, et al. Proteomic analysis for the assessment of diabetic renal damage in humans. Clin Sci (Lond) 2004;107:485-95.
131. Wittke S, Fliser D, Haubitz M, Bartel S, Krebs R, Hausadel F, et al. Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers. J Chromatogr A 2003;1013: 173-81.
132. Fliser D, Wittke S, Mischak H. Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes. Electrophoresis 2005;26:2708-16.
133. Haubitz M, Wittke S, Weissinger EM, Walden M, Rupprecht HD, Floege J, et al. Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int 2005;67:2313-20.
134. Weissinger EM, Wittke S, Kaiser T, Haller H, Bartel S, Krebs R, et al. Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. Kidney Int 2004;65:2426-34.
135. Decramer S, Wittke S, Mischak H, Zurbig P, Walden M, Bouissou F, et al. Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat Med 2006;12:398-400.
136. Liu J, Li M. Finding cancer biomarkers from mass spectrometry data by decision lists. J Comput Biol 2005;12: 971-9.
137. Vlahou A, Schellhammer PF, Mendrinos S, Patel K, Kondylis FI, Gong L, et al. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am J Pathol 2001;158:1491-502.
138. Kaiser T, Wittke S, Just I, Krebs R, Bartel S, Fliser D, et al. Capillary electrophoresis coupled to mass spectrometer for automated and robust polypeptide determination in body fluids for clinical use. Electrophoresis 2004;25:2044-55.
139. Carrette O, Demalte I, Scherl A, Yalkinoglu O, Corthals G, Burkhard P, et al. A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease. Proteomics 2003;3:1486-94.
140. Allard L, Burkhard PR, Lescuyer P, Burgess JA, Walter N, Hochstrasser DF, et al. PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. Clin Chem 2005;51:2043-51.
141. Haslam PL, Baughman RP. Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL. Eur Respir J 1999;14:245-8.
142. Magi B, Bargagli E, Bini L, Rottoli P. Proteome analysis of bronchoalveolar lavage in lung diseases. Proteomics 2006;6:6354-69.
143. Magi B, Bini L, Perari MG, Fossi A, Sanchez JC, Hochstrasser D, et al. Bronchoalveolar lavage fluid protein composition in patients with sarcoidosis and idiopathic pulmonary fibrosis: a two-dimensional electrophoretic study. Electrophoresis 2002;23:3434-44.
144. Wahlstrom J, Berlin M, Skold CM, Wigzell H, Eklund A, Grunewald J. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bron-choalveolar lavage fluid from patients with pulmonary sarcoidosis. Thorax 1999;54:339-46.
145. Oppenheim FG, Salih E, Siqueira WL, Zhang W, Helmerhorst EJ. Salivary proteome and its genetic polymorphisms. Ann N Y Acad Sci 2007;1098:22-50.
146. Tomosugi N, Kitagawa K, Takahashi N, Sugai S, Ishikawa I. Diagnostic potential of tear proteomic patterns in Sjogren's syndrome. J Proteome Res 2005;4:820-5.
147. Mann M, Jensen ON. Proteomic analysis of post-transitional modifications. Nat Biotechnol 2003;21:255-61.
148. Mann M, Jensen ON. Proteomic analysis of post-translational modifications. Nat Biotechnol 2003;21:255-61.
149. Seo J, Lee KJ. Post-translational modifications and their biological functions: proteomic analysis and systematic approaches. J Biochem Mol Biol 2004;37:35- 44.
150. Breimann L, Friemann J, Olshen RA, Stone JC. Classification and regression trees. Pacific Grove, CA: Wads-worth & Brooks/Cole Adv. Books Software.
151. Appel R, Hochstrasser D, Roch C, Funk M, Muller AF, Pellegrini C. Automatic classification of two-dimensional gel electrophoresis pictures by heuristic clustering analysis: a step toward machine learning. Electrophoresis 1988;9:136-42.
152. Hernandez P, Gras R, Frey J, Appel RD. Popitam: towards new heuristic strategies to improve protein identification from tandem mass spectrometry data. Proteomics 2003;3:870-8.
153. Burges CJC. A tutorial on support vector machines for pattern recognition. Knowledge Discovery and Data Mining 1998;121-67.
154. Girolami M, Rogers S. Variational Bayesian multinomial probit regression with Gaussian process priors. Neural Comput 2006;18:1790-817.
155. Kote-Jarai Z, Matthews L, Osorio A, Shanley S, Gid-dings I, Moreews F, et al. Accurate prediction of BRCA1 and BRCA2 heterozygous genotype using expression profiling after induced DNA damage. Clin Cancer Res 2006;12:3896-901.
156. Rho S, You S, Kim Y, Hwang D. From proteomics toward systems biology: integration of different types of proteomics data into network models. BMB Rep 2008;41:184-93.
157. Pan S, Zhang H, Rush J, Eng J, Zhang N, Patterson D, et al. High throughput proteome screening for biomarker detection. Mol Cell Proteomics 2005;4:182-90.
158. Orchard S, Hermjakob H, Apweiler R. The proteomics standards initiative. Proteomics 2003;3:1374-6.
159. Orchard S, Hermjakob H, Julian RK Jr, Runte K, Sherman D, Wojcik J, et al. Common interchange standards for proteomics data: public availability of tools and schema. Proteomics 2004;4:490-1.
160. Domon B, Aebersold R. Challenges and opportunities in proteomics data analysis. Mol Cell Proteomics 2006;5:1921-6.
161. Valet G. Cytomics as a new potential for drug discovery. Drug Discov Today 2006;11:785-91.
162. Valet G, Leary JF, Tarnok A. Cytomics-new technologies: towards a human cytome project. Cytometry A 2004;59:167-71.